PSP Research
Latest statistics and disclosures from PSP Research's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002106939
Tip: Access up to 7 years of quarterly data
Positions held by PSP Research consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for PSP Research
PSP Research holds 85 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 61.4 | $70M | 700k | 100.38 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 0.5 | $584k | 2.0k | 294.74 |
|
|
| Travere Therapeutics (TVTX) | 0.5 | $584k | 15k | 38.21 |
|
|
| Tyra Biosciences (TYRA) | 0.5 | $575k | 22k | 26.29 |
|
|
| Pharvaris N V (PHVS) | 0.5 | $569k | 21k | 27.75 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.5 | $554k | 3.3k | 170.00 |
|
|
| Celldex Therapeutics Com New (CLDX) | 0.5 | $553k | 20k | 27.16 |
|
|
| Cg Oncology (CGON) | 0.5 | $552k | 13k | 41.52 |
|
|
| Belite Bio Sponsored Ads (BLTE) | 0.5 | $551k | 3.4k | 159.96 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $550k | 2.6k | 213.24 |
|
|
| Apellis Pharmaceuticals (APLS) | 0.5 | $549k | 22k | 25.12 |
|
|
| Terns Pharmaceuticals (TERN) | 0.5 | $548k | 14k | 40.40 |
|
|
| Revolution Medicines (RVMD) | 0.5 | $547k | 6.9k | 79.65 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $547k | 22k | 25.01 |
|
|
| Bridgebio Pharma (BBIO) | 0.5 | $546k | 7.1k | 76.49 |
|
|
| Nurix Therapeutics (NRIX) | 0.5 | $545k | 29k | 18.97 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.5 | $544k | 19k | 29.04 |
|
|
| Kodiak Sciences (KOD) | 0.5 | $543k | 19k | 27.96 |
|
|
| Immunome (IMNM) | 0.5 | $542k | 25k | 21.48 |
|
|
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $542k | 34k | 15.95 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.5 | $541k | 6.9k | 78.99 |
|
|
| Halozyme Therapeutics (HALO) | 0.5 | $540k | 8.0k | 67.30 |
|
|
| Eyepoint Com New (EYPT) | 0.5 | $540k | 30k | 18.27 |
|
|
| Alkermes SHS (ALKS) | 0.5 | $540k | 19k | 27.98 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.5 | $538k | 6.8k | 79.11 |
|
|
| Mineralys Therapeutics (MLYS) | 0.5 | $538k | 15k | 36.29 |
|
|
| Arcellx Common Stock (ACLX) | 0.5 | $536k | 8.2k | 65.20 |
|
|
| Ptc Therapeutics I (PTCT) | 0.5 | $535k | 7.0k | 75.96 |
|
|
| Zymeworks Del (ZYME) | 0.5 | $535k | 20k | 26.33 |
|
|
| Supernus Pharmaceuticals (SUPN) | 0.5 | $535k | 11k | 49.70 |
|
|
| Protagonist Therapeutics (PTGX) | 0.5 | $535k | 6.1k | 87.34 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.5 | $535k | 14k | 37.42 |
|
|
| Roivant Sciences SHS (ROIV) | 0.5 | $534k | 25k | 21.70 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 0.5 | $534k | 14k | 38.64 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.5 | $534k | 44k | 12.08 |
|
|
| Liquidia Corporation Com New (LQDA) | 0.5 | $534k | 16k | 34.49 |
|
|
| Tarsus Pharmaceuticals (TARS) | 0.5 | $534k | 6.5k | 81.88 |
|
|
| Palvella Therapeutics Inc Ne (PVLA) | 0.5 | $532k | 5.1k | 104.67 |
|
|
| Rapport Therapeutics (RAPP) | 0.5 | $531k | 18k | 30.34 |
|
|
| Tg Therapeutics (TGTX) | 0.5 | $531k | 18k | 29.81 |
|
|
| Insmed Com Par $.01 (INSM) | 0.5 | $531k | 3.0k | 174.04 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.5 | $530k | 24k | 21.74 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 0.5 | $530k | 630.00 | 840.95 |
|
|
| Neurocrine Biosciences (NBIX) | 0.5 | $530k | 3.7k | 141.83 |
|
|
| Nuvalent Inc-a (NUVL) | 0.5 | $529k | 5.3k | 100.59 |
|
|
| Incyte Corporation (INCY) | 0.5 | $528k | 5.4k | 98.77 |
|
|
| Cytokinetics Com New (CYTK) | 0.5 | $528k | 8.3k | 63.54 |
|
|
| Miragen Therapeutics (VRDN) | 0.5 | $528k | 17k | 31.12 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $528k | 20k | 26.71 |
|
|
| Wave Life Sciences SHS (WVE) | 0.5 | $528k | 31k | 17.00 |
|
|
| Stoke Therapeutics (STOK) | 0.5 | $528k | 17k | 31.74 |
|
|
| Apogee Therapeutics (APGE) | 0.5 | $527k | 7.0k | 75.48 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 0.5 | $527k | 11k | 46.55 |
|
|
| United Therapeutics Corporation (UTHR) | 0.5 | $526k | 1.1k | 487.25 |
|
|
| Maze Therapeatics (MAZE) | 0.5 | $525k | 13k | 41.43 |
|
|
| Dianthus Therapeutics (DNTH) | 0.5 | $524k | 13k | 41.21 |
|
|
| Denali Therapeutics (DNLI) | 0.5 | $524k | 32k | 16.51 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $524k | 1.3k | 397.65 |
|
|
| Exelixis (EXEL) | 0.5 | $524k | 12k | 43.83 |
|
|
| Xenon Pharmaceuticals (XENE) | 0.5 | $523k | 12k | 44.82 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $523k | 15k | 35.08 |
|
|
| Celcuity (CELC) | 0.5 | $523k | 5.2k | 99.74 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.5 | $522k | 13k | 41.25 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.5 | $521k | 8.8k | 59.43 |
|
|
| Ocular Therapeutix (OCUL) | 0.5 | $520k | 43k | 12.14 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $519k | 892.00 | 582.34 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.5 | $519k | 25k | 21.01 |
|
|
| Spyre Therapeutics Com New (SYRE) | 0.5 | $519k | 16k | 32.76 |
|
|
| Viking Therapeutics (VKTX) | 0.5 | $518k | 15k | 35.18 |
|
|
| Immunovant (IMVT) | 0.5 | $516k | 20k | 25.42 |
|
|
| Beam Therapeutics (BEAM) | 0.4 | $508k | 18k | 27.72 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $507k | 4.7k | 107.04 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.4 | $506k | 10k | 50.64 |
|
|
| Inhibrx Biosciences (INBX) | 0.4 | $505k | 6.4k | 79.00 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $502k | 9.6k | 52.44 |
|
|
| Immunocore Hldgs Ads (IMCR) | 0.4 | $501k | 14k | 34.71 |
|
|
| Kymera Therapeutics (KYMR) | 0.4 | $494k | 6.3k | 77.81 |
|
|
| Upstream Bio (UPB) | 0.4 | $479k | 18k | 27.15 |
|
|
| Olema Pharmaceuticals (OLMA) | 0.4 | $477k | 19k | 25.00 |
|
|
| Cogent Biosciences (COGT) | 0.4 | $470k | 13k | 35.52 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $467k | 6.7k | 69.55 |
|
|
| Mind Medicine Mindmed Com New (MNMD) | 0.4 | $467k | 35k | 13.39 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.4 | $444k | 6.7k | 66.39 |
|
|
| Alumis (ALMS) | 0.4 | $427k | 44k | 9.76 |
|
|
| Dyne Therapeutics (DYN) | 0.4 | $421k | 22k | 19.56 |
|
Past Filings by PSP Research
SEC 13F filings are viewable for PSP Research going back to 2025
- PSP Research 2025 Q4 filed Feb. 6, 2026